JBIO

Jade Biosciences, Inc. - Common Stock (JBIO)

About Jade Biosciences, Inc. - Common Stock (JBIO)

Jade Biosciences, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake on July 27, 2018 and is headquartered in Waltham, MA.

Details

Daily high

$23.60

Daily low

$22.87

Price at open

$23.07

52 Week High

$28.00

52 Week Low

$6.71

Market cap

1.5B

Dividend yield

Volume

721,657

Avg. volume

846,777

P/E ratio

-8.97

Jade Biosciences, Inc. - Common Stock News